Jens Hillengass, MD, PhD

Chief of Myeloma, Professor of Oncology

Jens Hillengass, MD, PhD

While in Medical School I focused my research on the investigation of morphological and functional imaging of hematological diseases, especially monoclonal plasma cell disorders. Our group has established magnetic resonance imaging (MRI) and computed tomography (CT) as novel standard diagnostic techniques in multiple myeloma and its precursor diseases. The discovery of a heterogeneity in growth patterns in myeloma has led us to focus on the significance of a spatial heterogeneity for genomic assessment and treatment monitoring especially minimal residual disease assessment.

The huge amount of information coming from whole body imaging motivated us to start the development of software tools to support the radiologist and nuclear medicine specialist in evaluating the clinical data and to make this "big imaging data" available for research. Dealing with myeloma patients in advanced stages of the disease and analyzing imaging results of modern imaging techniques has led to a deeper interest in myeloma bone disease, where we have started to investigate the influence of physical activity on pain, quality of life and skeletal related events. Having been responsible for the largest autologous stem cell transplant program in Germany has also motivated me to investigate how treatment with high dose chemotherapy can be improved. 


Related Videos

Lifestyle Interventions for Multiple Myeloma Patients Video

Lifestyle Interventions for Multiple Myeloma Patients

As innovative treatments have improved outcomes in multiple myeloma, patients now live longer and look to get back to a similar quality of life they enjoyed before their diagnosis.

Reaching Deep Remissions with a New Therapy for Multiple Myeloma Patients Video

Reaching Deep Remissions with a New Therapy for Multiple Myeloma Patients

Roswell Park is spearheading efforts to study innovative CAR T-cell therapies in addition to offering traditional treatment approaches.

Mapping the Battlefield: Imaging of Multiple Myeloma Video

Mapping the Battlefield: Imaging of Multiple Myeloma

Jens Hillengass, MD, shares a history of myeloma imaging, the variety of sophisticated imaging techniques available, and shares several examples to help determine diagnosis.

New Imaging Guidelines for Monoclonal Plasma Cell Disorders Video

New Imaging Guidelines for Monoclonal Plasma Cell Disorders

Jens Hillengass, MD, Chief of Myeloma at Roswell Park Comprehensive Cancer Center, reviews new imaging guidelines for multiple myeloma, as well as other monoclonal plasma cell disorders, that were published in The Lancet Oncology.

Transplant Eligibilty for Myeloma Patients Video

Transplant Eligibilty for Myeloma Patients

Jens Hillengass, MD, gives a presentation on myeloma treatments and the types of patients who are transplant eligible and those who are non-transplant eligible.

The New York State Cellular Therapy Consortium Video

The New York State Cellular Therapy Consortium

Hosted by Roswell Park Comprehensive Cancer Center | Thursday, May 25, 2023 | 6-8 p.m.